| scholarly article | Q13442814 |
| P50 | author | Lutz Heinemann | Q65055050 |
| P2093 | author name string | David Price | |
| Norbert Hermanns | |||
| Andreas Liebl | |||
| Claudia Graham | |||
| Dorothee Deiss | |||
| Matthias Kaltheuner | |||
| P2860 | cites work | Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial | Q38443982 |
| Outcome measures for outpatient hypoglycemia prevention studies | Q38693810 | ||
| Nationwide reduction in the frequency of severe hypoglycemia by half. | Q41664753 | ||
| Glycaemic impact of patient-led use of sensor-guided pump therapy in type 1 diabetes: a randomised controlled trial | Q42618876 | ||
| Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes | Q43001906 | ||
| The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise | Q43456988 | ||
| Real-time continuous glucose monitoring or continuous subcutaneous insulin infusion, what goes first?: results of a pilot study | Q43810058 | ||
| Short-term effects on patient satisfaction of continuous glucose monitoring with the GlucoDay with real-time and retrospective access to glucose values: a crossover study | Q43851100 | ||
| Continuous glucose monitoring: quality of hypoglycaemia detection | Q44098109 | ||
| Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia | Q44243542 | ||
| Severe hypoglycemia and ketoacidosis over one year in Italian pediatric population with type 1 diabetes mellitus: a multicenter retrospective observational study | Q44319656 | ||
| Structured treatment and teaching programs and an improvement in private health care lead to a better quality of diabetes care. JEVIN, a population-based trial 1989/90 up to 1999/2000 | Q44481107 | ||
| Assessing psychosocial distress in diabetes: development of the diabetes distress scale | Q45285718 | ||
| JDRF randomized clinical trial to assess the efficacy of real-time continuous glucose monitoring in the management of type 1 diabetes: research design and methods | Q46337569 | ||
| Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study | Q46420596 | ||
| Effect of antecedent glucose control on cerebral function during hypoglycemia | Q48797544 | ||
| Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaS | Q50642265 | ||
| The U.K. service level audit of insulin pump therapy in adults. | Q50764909 | ||
| Threshold-based insulin-pump interruption for reduction of hypoglycemia. | Q50888948 | ||
| Severe hypoglycemic episodes: a persistent threat for children with Type 1 diabetes mellitus and their families | Q56977700 | ||
| Lack of preservation of higher brain function during hypoglycaemia in patients with intensively-treated IDDM | Q57420328 | ||
| Restoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes | Q57420344 | ||
| Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled Type 1 diabetes; a randomized controlled trial | Q58886172 | ||
| Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM | Q70495234 | ||
| The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial | Q71919192 | ||
| Reversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM | Q72800093 | ||
| Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans | Q72877437 | ||
| Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group | Q72990022 | ||
| Intensified insulin therapy and the risk of severe hypoglycaemia | Q73617182 | ||
| Prevalence of impaired awareness of hypoglycaemia in adults with Type 1 diabetes | Q81011993 | ||
| Nocturnal glucose control with an artificial pancreas at a diabetes camp | Q86210570 | ||
| Continuous glucose monitoring systems for type 1 diabetes mellitus | Q24203866 | ||
| Standards of medical care in diabetes--2013 | Q29620309 | ||
| Dexcom G4AP: an advanced continuous glucose monitor for the artificial pancreas | Q30409815 | ||
| Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes | Q30427586 | ||
| Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms | Q30463772 | ||
| Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy | Q30837772 | ||
| Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial | Q33556781 | ||
| Improved results in paediatric diabetes care using a quality registry in an improvement collaborative: a case study in Sweden | Q33670330 | ||
| Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data | Q33954163 | ||
| Hemoglobin A1c Levels and risk of severe hypoglycemia in children and young adults with type 1 diabetes from Germany and Austria: a trend analysis in a cohort of 37,539 patients between 1995 and 2012 | Q34301297 | ||
| Youth and parent satisfaction with clinical use of the GlucoWatch G2 Biographer in the management of pediatric type 1 diabetes | Q34482263 | ||
| Response to nocturnal alarms using a real-time glucose sensor | Q34696490 | ||
| Effect of continuous glucose monitoring on hypoglycemia in type 1 diabetes | Q34718324 | ||
| Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry | Q34768952 | ||
| Reducing rates of severe hypoglycemia in a population-based cohort of children and adolescents with type 1 diabetes over the decade 2000-2009 | Q35408129 | ||
| Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens: a 1-year multicenter study | Q35898281 | ||
| Defining and reporting hypoglycemia in diabetes: a report from the American Diabetes Association Workgroup on Hypoglycemia | Q36108419 | ||
| The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial | Q36353388 | ||
| System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197. | Q36605699 | ||
| Comparative analysis of the efficacy of continuous glucose monitoring and self-monitoring of blood glucose in type 1 diabetes mellitus. | Q36605704 | ||
| Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept | Q36720416 | ||
| The effect of continuous glucose monitoring in well-controlled type 1 diabetes | Q37269538 | ||
| Hypoglycemia: still the limiting factor in the glycemic management of diabetes | Q37321737 | ||
| Factors predictive of use and of benefit from continuous glucose monitoring in type 1 diabetes | Q37400821 | ||
| Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study | Q37437141 | ||
| Comparative effectiveness and safety of methods of insulin delivery and glucose monitoring for diabetes mellitus: a systematic review and meta-analysis. | Q38025029 | ||
| Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review. | Q38044025 | ||
| Mechanisms of hypoglycemia-associated autonomic failure in diabetes | Q38123894 | ||
| Evidence for continuous glucose monitoring: sufficient for reimbursement? | Q38154975 | ||
| A population-based study of risk factors for severe hypoglycaemia in a contemporary cohort of childhood-onset type 1 diabetes | Q38425571 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | type-1 diabetes | Q124407 |
| hypoglycemia | Q202758 | ||
| research design | Q1438035 | ||
| P304 | page(s) | 651-662 | |
| P577 | publication date | 2015-03-09 | |
| P1433 | published in | Journal of Diabetes Science and Technology | Q15755249 |
| P1476 | title | HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Da | |
| P478 | volume | 9 |
| Q55252190 | Healthcare Resource Waste Associated with Patient Nonadherence and Early Discontinuation of Traditional Continuous Glucose Monitoring in Real-World Settings: A Multicountry Analysis. |
| Q92174720 | Impact of CGM on the Management of Hypoglycemia Problems: Overview and Secondary Analysis of the HypoDE Study |
| Q49834635 | Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial |
| Q37054685 | The Potential Cost Implications of Averting Severe Hypoglycemic Events Requiring Hospitalization in High-Risk Adults With Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring |
Search more.